Bone morphogenetic protein signaling suppresses tumorigenesis at gastric epithelial transition zones in mice

Sylvia A Bleuming1, Xi C He, Liudmila L Kodach

  • 1Center for Experimental and Molecular Medicine, Academic Medical Center, Amsterdam, The Netherlands.

Cancer Research
|September 7, 2007
PubMed

Insights

Bone morphogenetic protein (BMP) signaling suppresses stomach cancer. Loss of Bmpr1a signaling in mice caused neoplastic lesions in gastric junctional zones, indicating BMPR1A

Area of Science:

  • Gastroenterology
  • Molecular Biology
  • Oncology

Background:

  • Bone morphogenetic protein (BMP) signaling is a known suppressor of oncogenesis in the gastrointestinal tract.
  • The specific role of BMP signaling in gastric tumorigenesis, particularly in distinct epithelial zones, remains less understood.

Purpose of the Study:

  • To investigate the role of Bone Morphogenetic Protein Receptor Type 1A (Bmpr1a) signaling in gastric tumorigenesis.
  • To determine if Bmpr1a signaling influences epithelial cell fate and proliferation in specific gastric transition zones.

Main Methods:

  • Conditional inactivation of the Bmpr1a gene in mice.
  • Histological analysis of gastric tissues to identify neoplastic lesions.
  • Assessment of cell differentiation markers (e.g., Muc5ac) and precursor cell proliferation in junctional zones.

Main Results:

  • Conditional inactivation of Bmpr1a led to the development of neoplastic lesions in the squamocolumnar and gastrointestinal transition zones of the stomach.
  • These junctional zones exhibited a lack of differentiated cell types and increased precursor cell proliferation compared to adjacent epithelium.
  • Foveolar cells in the gastrointestinal junctional zone lacked the expression of the marker Muc5ac.

Conclusions:

  • BMP signaling through Bmpr1a plays a critical role in suppressing tumorigenesis at distinct gastric epithelial junctional zones.
  • These gastric junctional zones differ from adjacent epithelium in cellular differentiation and proliferation, making them susceptible to neoplastic development upon Bmpr1a loss.
  • Targeting BMP signaling pathways may offer a therapeutic strategy for preventing or treating gastric cancers originating in these specific zones.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...